Anti-EGFR (Cetuximab), Chimeric Antibody

Anti-EGFR (Cetuximab), Chimeric Antibodyis available at Gentaur for Next week Delivery.

Description: Cetuximab is a recombinant human/mouse chimeric epidermal growth factor receptor (EGFR) monoclonal antibody. Epidermal growth factor receptor (EGFR) is a receptor found on both normal and tumor cells that is important for cell growth. Cetuximab is an EGFR inhibitor, used to treat cancer by blocking the activity of EGFR and keep cancer from growing. Cetuximab can form a bridge that trigger an immune response by binding to the EGFR on the tumor cells. It is used for the treatment of EGFR-expressing, metastatic colorectal cancer.

Immunogen Sequence:Human A431 cells

Target Alternative Name:Erbitux

Species Reactivities:Human

Tag Line:Monoclonal human IgG1 antibody against human EGFR

Formulation:100 ug (2 mg/ml) of antibody in Phosphate buffered saline, pH 7.4.

Purification: human IgG1 was expressed in a mouse cell line. IgG was purified from mouse cell culture supernatant by protein A chromatography.

Application:Neutralization, ELISA

Positive Control:/

Application And Usages:Neutralization : 1-20 μg/ml; ELISA: 2μg/ml

Handling:The antibody solution should be gently mixed before use